GlycoForm is using its patented technology and expertise to produce novel molecules, in addition to superior biosimilars (GFBioBetters) and to salvage molecules with poor pharmacokinetics and pharmacodynamics (GFBioRetrieve).
GFBioRetrieve
GLY205 using sugar conjugation to enhance the transport of molecules across membranes.
GFBioBetters
GLY202 glycosylation of a peptide to produce a long acting single glycoform active upon the haematopoeitic system.
GFBioTherapeutics
GLY302 using sugars to target an immunomodulator to improve anti-infective activity.